Tailoring prevention to a person's metabolic profile, especially addressing insulin resistance and inflammation , shows ...

Unlike cervical cancer, endometrial cancer often presents with symptoms at an early stage, per the Mayo Clinic, resulting in ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...

GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

Endometrial cancer usually returns within three years after treatment. Most of the studies that looked at recurrence rates lasted less than five years, so it's hard to know exactly how many ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

GlaxoSmithKline Pharmaceuticals said it is bringing in Jemperli and Zejula to India, marking its re-entry into the cancer ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...

A writer details her mother’s fight with endometrial cancer and how she’s learned how to grapple with heart-wrenching grief.

The FDA has approved a new drug for some adult patients with endometrial cancer. Jemperli (dostarlimably) — made by U.K. company GSK — is intended for primary advanced or recurrent disease.

Black women represented just under 10 percent of the 208,587 uterine cancer cases diagnosed in the United States between 2000 and 2017, but they made up almost 18 percent of the nearly 16,797 ...